SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
+30.99%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.19B
AUM Growth
+$2.19B
(+18%)
Cap. Flow
-$50.9M
Cap. Flow
% of AUM
-2.33%
Top 10 Holdings %
Top 10 Hldgs %
47.59%
Holding
101
New
13
Increased
23
Reduced
21
Closed
13
Top Buys
| 1 |
Ultragenyx Pharmaceutical
RARE
|
$69.2M |
| 2 |
Goldman Sachs
GS
|
$42.6M |
| 3 |
TSMC
TSM
|
$40.4M |
| 4 |
Ferguson
FERG
|
$34M |
| 5 |
Apollo Global Management
APO
|
$32.5M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$91M |
| 2 |
Advanced Micro Devices
AMD
|
$53.5M |
| 3 |
Wynn Resorts
WYNN
|
$42.5M |
| 4 |
NVIDIA
NVDA
|
$38.5M |
| 5 |
Amazon
AMZN
|
$38.2M |
Sector Composition
| 1 | Healthcare | 68.4% |
| 2 | Technology | 8.43% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Communication Services | 5.73% |
| 5 | Industrials | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Waters Corp
WAT
$18B
| $1.04M | 0.05% |
3,150
| – | – |
|
77
Intuitive Surgical
ISRG
$170B
| $1.04M | 0.05% |
3,070
| – | – |
|
78
Avantor
AVTR
$9.18B
| $873K | 0.04% |
38,250
| – | – |
|
79
DexCom
DXCM
$29.5B
| $730K | 0.03% |
5,880
| – | – |
|
80
Agilent Technologies
A
$35.7B
| $694K | 0.03% |
4,990
| – | – |
|
81
Benitec Biopharma
BNTC
$348M
| $660K | 0.03% |
204,220
| – | – |
|
82
Idexx Laboratories
IDXX
$51.8B
| $511K | 0.02% |
920
| – | – |
|
83
Veralto
VLTO
$26.4B
| $450K | 0.02% |
+5,475
| New | +$450K |
|
84
Morgan Stanley
MS
$240B
| $448K | 0.02% |
+4,800
| New | +$448K |
|
85
United Therapeutics
UTHR
$13.8B
| $299K | 0.01% |
1,360
| – | – |
|
86
Charles River Laboratories
CRL
$8.04B
| $239K | 0.01% |
+1,010
| New | +$239K |
|
87
Bio-Techne
TECH
$8.5B
| $201K | 0.01% |
+2,600
| New | +$201K |
|
88
Alvotech
ALVO
$2.51B
| – | – |
-928,402
| Closed | -$8.47M |
|
89
BioNTech
BNTX
$24B
| – | – |
-40,970
| Closed | -$4.45M |
|
90
Capital One
COF
$145B
| – | – |
-181,660
| Closed | -$17.6M |
|
91
KraneShares CSI China Internet ETF
KWEB
$8.49B
| – | – |
0
| – | – |
|
92
Eli Lilly
LLY
$657B
| – | – |
-39,100
| Closed | -$21M |
|
93
Nurix Therapeutics
NRIX
$714M
| – | – |
-280,760
| Closed | -$2.21M |
|
|
94
NVIDIA
NVDA
$4.24T
| – | – |
-88,548
| Closed | -$38.5M |
|
95
Protagonist Therapeutics
PTGX
$3.67B
| – | – |
-108,308
| Closed | -$1.81M |
|
96
RH
RH
$4.23B
| – | – |
-80,989
| Closed | -$21.4M |
|
97
Sarepta Therapeutics
SRPT
$1.78B
| – | – |
-6,058
| Closed | -$734K |
|
98
Wells Fargo
WFC
$263B
| – | – |
-428,506
| Closed | -$17.5M |
|
|
99
Wynn Resorts
WYNN
$13.2B
| – | – |
-460,048
| Closed | -$42.5M |
|
|
OHAAW
100
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
| – | – |
-72,605
| Closed | -$2.01K |
|